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m983131 Implantable Defibrillator Event Ratea in Patients
with Syncope of Unknown Origin and Induced
Suetained Ventricular Tachycardia: Comparison
with Patients with Documented Ventricular
Tachycardia
N.P.Andrews, R.1.Fogel, J.J. Evans, E.N. Prystowsky. Indiana Heart
/nstitute, Indianapolis, IN, USA
Induced sustained VT (VT-S) at EPS is typically considered diagnostic in pts
withsynoope of unknown origin (SUO). To validate this concept, we com-
pared VTS event rates during follow-up in 2 groups of pts with implantable
defibrillator (lCD) who had induced V_FSat EPS but were discharged re-
ceiving no antiarrhyfhmic drugs: Gr. I (N = 22) had SUO and Gr. II (N = 33)
had documented VT-S. All ICDShad stored electrograms or RR intervals. Gr.
I vs Gr. II had similar age (69 + 2 vs 66 + 1 yrs, X + SEM), gender (82% vs
76% male), LVEF (30 + 3% vs 29 + 2%), and ischemic heart disease (63%
vs 91%). CHF occurred more often in Gr. I (64% vs 34%, p = 0.05). Induction
of VT-S in Gr. I vs Gr. II had similar (p = NS) S1-S2 (264 + 3 vs 279 + 12
ins), S2-S3 (216 + 5 vs 228 + 5 ins), and S3-S4 (205 + 6 vs 212 + 6 ins),
but 3 extrastimuli were needed more commonly in Gr. II (59% vs 45%, p =
NS). Cycle length of induced VT-S was shorter in Gr. I (256+7 ms) than Gr.
II (282+7 ms, p < 0.01). Median follow-up was20 mos for Gr. I and 22 mos
for Gr. H.Kaplan-Meier analysis of the time to first ICD therapy for Gr. I and
Gr. II produced overlapping curves (p = 0.7), with 1year ICD therapy of 56 +
11% (Gr. 1)and 53 + 9% (Gr. H).We conclude in pts with SUO and induced
VT-S at EPS: (1) documented VT-S occura commonly during follow-up and
is similar to recurrent VT-S rates in pts with known VT-S; and (2) aggressive
therapy is warranted to treat the VT-S.
1983-133) ~tabi,i~OfDefibrillatiOn ThreSholdsAfierl
Month With the Angeion Sentinel 2000
Implantable Defibrillator
M. Niebauer, J. Shewchik, K. Lock, P.Tchou. The C/eve/and C/inic,
Cleveland, OH, USA, Angaion Corp, Minneapolis, MN, USA
The stability of defibrillation thresholds (DFT) for implantable cardioverter
defibriliators (lCD) is important when selecting shock intensity, since a safety
margin of 10 Joules (J) or twice DFT has been suggested. Methods: We
report the initial energy DFT determinations of 10 patients (6 Male/2 Female:
age = 63.1 + 6.4) after implantation of the Angeion Sentinel 2000 ICD and
compared these values to those obtained at 1 month follow-up. This small
(58 cc) ICD delivers a 95 KF capacitance and a tuned biphasic shock (up
to 26.7 J stored) from the right ventricular electrode of a non-thoracotomy
lead to a second electrode in the superior vena cava coupled with a pre-
pectoral “can”. Initial step-down energy DFT’s were obtained in 6 patients at
implantation and in 4 during pre-discharge testinQ.This initial measurement
was compared to the DFT value at 1 month follow-up. Results: The mean
stored energy and shock impedance values at DFT are shown in the Table
below. In 5 patients, the DFT energy increased from 2.0 to 3.4 J (mean= 2.5
+ 0.6 J) and in 3 others the DFT decreased from 3.6 to 6.0 J (mean = 5.6
+ 1.6 J), The maximum DFT energy was 11.6 J initially and at 1 month the
maximum was 14.3J. One patient failed to meet implantation criteria due to a
high DFT. However, he also failed to meet criteria for a 34 J nonthoracotomy
ICD and subsequently had an epicardial system implanted with marginal
DFT’s (25 J).
DFT Energy(Joules) Impedance (Ohms)
Initial 9.1 k 2.6 43.2 + 8.2
I. Month 8.7 + 3.7 NS 42.2 + 6.3 NS
m983132 Actuarial Eetimates of Totel Mortality MayUnderestimate Survival Benefit of Implantable
Cardioverter/Defibrillators in Patients Referred for
Cardiac Tranaplantation
M.O. Sweeney, J. Newell, B. McGovern, H. Garan, J.N. Ruskin,
M. Semigran, G.W. Dec. Brigham and Women’s Hospital, Massachusetts
General Hospital, Boston, MA, USA
Actuarial analysis has previously suggested no difference in long-term sur-
vival of ptawith severe heart failure and implantable eardioverter/defibrillators
(lCD), despite reduction of sudden death, due to prohibitive nonsudden death
rates. However,the effect of ICDSon near-term survival in ptsreferredforcar-
diactranaplantation may be different: We compared total mortality between 2
subgroups of 59 pts with severe heart failure, prior history of sustained VTNF,
and ICDS referred for transplantation: 36/59 (61%) with shocks for repid,
symptomatic VT or VF, and 23/59 (sg~.) without shocks during follow-up.
Rhythm (VTiVF) was mnfirmad by surface EKG or retrieved storedintracar-
diac eleotrograms/cyClelength log in all cases. Baseline variables including
age, gender, heati disease, index arrhythmia, hemodynamics, ejection frac-
tion, heart failure claas and medical therapies were similar. Time to firat
successful termination of confirmed VT/VF was uaed aa a mortality proxy.
Shock-free and proxy mortality rates were different (p < 0.0005). Actuarial
total mortality and transplantation rates were equivalent between shock and
shock-free subgroups at 12 months.
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Cone/uaion:The absence of a difference in near-term mortality between
ICDsubgroups may not mean the absence of a survival benefit attributable to
successful ICD termination of recurrent VTPJF.Equivalent near-term sufvival
and transplantation rates in ICD pts with successful termination of recurrent
VTNF versus similar pts without VTNF implies an ICD survival benefit not
reflected in mnventional actuarial analysis of total mortality.
NS = Notsignificantlydifferentfrom initialvalue.
Conclusions: These results show that the mean DFT’s obtained at either
implantation or pre-discharge of the Angeion Sentinel 2000 are stable at 1
month follow-up and suppotts the view that ICD’Swith smaller capacitors can
be implanted with adequate safety margins.
1983-1341Nonprogrammablel~~ArrhWh~ia~e~ection:
Approximate Entropy, Kurtoais, and Cycle Length
D.A. Igel, K.L. Arheart, B.L. Wilkoff. The C/eve/and C/inic Foundation,
Cleveland, OH, USA
Two problems hinder the performance of ICD arrhythmia detectors that use
autothreshold sensing and programmed cycle length (CL) cutoffs: (1) under-
sensing of low amplitude ventricular fibrillation (VF), and (2) poor discrimina-
tion of monomorphic ventricular tachycardia (MVT) from VF.Toovercomethe
problems of the programmable detectors, we modeled a nonprogrammabie
arrhythmia detector that employs an approximate entropy statistic (ApEn
(N, m, r)). ApEn quantifies the regularity of a time series of size N by es-
timating the log probability that similar patterns of length m remain similar
(within a toierance r) at the m + IS’ point. Numerous m and r values were
evaluated from a database of 115 VF, 43 MVT, and 77 NSR signals. The
nonprogrammable defibrillator was modeled by a discriminant function de-
rived from a combination of ApEn (N = 4500, m = 2, r = 0.26), kurtosis, and
CL; these variables provided the best detection accuracy (p -=0.001). The
performance of the nonprogrammable detector was compared to that of a
programmable detector. The programmable detector model had autothresh-
old sensing, and it was programmed with standard logic (CL >500 = NSR,
333s CLs 500 = MVT,CL <333 = VF). The programmable detector failed
to identify 5 of 115VF cases, while all 115VF eases were identified as tach-
yarrhythmias by the nonprogrammable detector. Discrimination of MVTfrom
VF improved from 60% to 91% by the use of the nonprogrammable detector.
The nonprogremmable detector had greater sensitivity to VF and increased
discrimination of MVT from VF compared to the traditional techniques that
required the programming of CL cutoffs.
1983-1351 The Effect of Ventricular ShOcks On Cardiac
output
T. Tokano, J. Souza, B.P. Knight, M. Bahu, R. Weiss, A. Zivin, D. Bach,
R. Goyal, E.G. Daoud, KC. Man, F. Morady, S.A. Strickberger. The
Univeraityof Michigan Medical CerrtecAnn Arboc Michigan, USA
This studytested the hypothesisthat NTLICDshocks adversely affect cardiac
output (CO). CO was determined by calculating mitral valve inflow (MVI) with
transesophogeal doppler during implantation of the same NTL ICD system
in 11pts. MVI was calculated before, and immediately, 1 rein, and 2 min after
shocks were delivered during DFT testing (15 J, 10 J, 5 J, and 30 J (Max J)).
MVI was also calculated after a 1 J and Max J shock during sinus rhythm
